학술논문
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis
Document Type
Article
Author
Source
In: Journal of Clinical Endocrinology and Metabolism . (Journal of Clinical Endocrinology and Metabolism, 1 November 2014, 99(11):E2207-E2215)
Subject
Language
English
ISSN
19457197
0021972X
0021972X